Idera Pharmaceuticals Inc news

   Watch this stock
Showing stories 1 - 10 of about 47   

Articles published

IDRA 2.49 0.00 (0.00%)
price chart
Idera Pharmaceuticals Expands Pipeline by Initiating Clinical Development of ...
CAMBRIDGE, Mass., Oct. 14, 2014 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (Nasdaq:IDRA), a clinical-stage biopharmaceutical company developing nucleic acid therapeutics for patients with cancer and rare diseases, today announced it has ...
Related articles »  
Top News: Citigroup Inc. (NYSE:C), Idera Pharmaceuticals, Inc. (NASDAQ:IDRA ...
Idera Pharmaceuticals Inc (NASDAQ:IDRA) announced the net loss of $8.4 million in 2Q2014 comparable to the net loss of $5.6 million a year ago.
Related articles »  
Market Momentum on Biotech Stocks - Amicus Therapeutics, Progenics Pharma ...
Investor-Edge has initiated coverage on the following equities: Amicus Therapeutics Inc. (NASDAQ: FOLD), Progenics Pharmaceuticals Inc. (NASDAQ: PGNX), Threshold Pharmaceuticals Inc. (NASDAQ: THLD), Idera Pharmaceuticals Inc. (NASDAQ: IDRA), ...
Related articles »  
SunPower (NASDAQ:SPWR) in Imported Declaration with Idera ...
Idera Pharmaceuticals Inc (NASDAQ:IDRA) (Read Latest Free Analytic Facts on IDRA and Be Updated) reported on Tuesday that it has advanced IMO-9200 into Phase 1 clinical development after acceptance of an Investigational New Drug application by the ...
Trending Stocks: Idera Pharmaceuticals (NASDAQ:IDRA), Juniper Networks ...  WallStreet Scope
Related articles »  
Investor's Alert- Capitol Federal Financial, Inc. (CFFN), Idera ...
Las Vegas, NV �October 17, 2014� (TechSonian) �Capitol Federal Financial, Inc.(NASDAQ:CFFN) posted that itis the holding company for Capitol Federal Savings Bank. Capitol Federal Savings Bank is a federally charted stock savings bank. The Bank has ...
Related articles »  
Leading Health Care Stock for Small-Cap Stars is Enanta Pharmaceuticals Inc ...
Idera Pharmaceuticals Inc. gained 2.94% to $2.45. The gains came on a volume of 717,177 shares against an average daily volume of 697,896 shares.
Related articles »  
Health Stock in Focus: Lakeland Industries, Inc. (NASDAQ:LAKE), BioCryst ...
Idera Pharmaceuticals Inc (NASDAQ:IDRA) a clinical-stage biopharmaceutical firm declared it has advanced IMO-9200 into Phase 1 clinical development subsequent acceptance of an Investigational New Drug submission by the United State Food and Drug ...
Stocks on Trader's Radar �Globus Medical Inc (GMED), Northern Oil & Gas, Inc ...
Las Vegas, NV - September 16, 2014 - (TechSonian) �Globus Medical Inc (GMED) a medical device company, focuses on the design, development, and commercialization of musculoskeletal implants that promote healing in patients with spine disorders.
Related articles »  
Active Watch List: EOG Resources, Inc. (NYSE:EOG), QEP Resources, Inc ...
Idera Pharmaceuticals Inc (NASDAQ:IDRA) (Read Latest Free Analytic Facts on IDRA and Be Updated) reported on Tuesday that it has advanced IMO-9200 into Phase 1 clinical development after acceptance of an Investigational New Drug application by the ...
Related articles »  
Buzzing Stocks: China Telecom Corporation Limited (ADR)(CHA) Arrowhead ...
Bruce Given, M.D., the CEO, will attend the conference on behalf of Arrowhead. The conference is scheduled on September 26, 2014. Investors can access the live webcast on the official website.